Aude Houchard
Overview
Explore the profile of Aude Houchard including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
304
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chan J, Ribeiro-Oliveira Jr A, Houchard A, Dennen S, Liu Y, Naga S, et al.
Adv Ther
. 2025 Mar;
PMID: 40080241
Introduction: This study investigated the burden of comorbidities and concomitant non-cancer medications and their cost in patients with neuroendocrine tumors (NETs). Methods: Adults with gastroenteropancreatic (GEP)-NETs and lung-NETs, with or...
2.
Chen J, Bai L, Cheng H, Chan S, Zou J, Shi X, et al.
Oncol Ther
. 2024 Aug;
13(1):69-83.
PMID: 39215958
Introduction: There is a lack of data on the efficacy, effectiveness, and safety of lanreotide autogel in patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs) of Chinese ethnicity. This noninterventional, retrospective study...
3.
Matveev V, Gao X, Kopyltsov E, Luo J, Wei Q, Ye D, et al.
Asia Pac J Clin Oncol
. 2024 Jul;
20(6):738-746.
PMID: 38958195
Aim: To evaluate the efficacy and safety of triptorelin after radical prostatectomy (RP) in patients with negative lymph nodes. Methods: PRIORITI (NCT01753297) was a prospective, open-label, randomized, controlled, phase 4...
4.
OToole D, Kunz P, Webb S, Goldstein G, Khawaja S, McDonnell M, et al.
Adv Ther
. 2024 Mar;
41(6):2531-2533.
PMID: 38480663
No abstract available.
5.
Brown J, Harrow B, Marciniak A, McCarthy C, Houchard A, Cirneanu L, et al.
Drugs Real World Outcomes
. 2024 Jan;
11(2):195-207.
PMID: 38265633
Background And Objective: The tyrosine kinase inhibitors cabozantinib and axitinib have been widely used in England to treat advanced renal cell carcinoma following prior vascular endothelial growth factor-targeted therapy, but...
6.
Fleseriu M, Barkan A, Brue T, Duquesne E, Houchard A, Del Pilar Schneider M, et al.
J Endocr Soc
. 2023 Sep;
7(10):bvad104.
PMID: 37705695
Context: Treatment of acromegaly is multimodal for many patients, and medical treatments include somatostatin receptor ligands (SRLs), dopamine agonists (DAs), and growth hormone receptor antagonists (GHRAs). However, recent real-world evidence...
7.
Hautefeuille V, Walter T, Do Cao C, Coriat R, Dominguez S, Mineur L, et al.
Eur J Endocrinol
. 2023 Aug;
189(2):281-289.
PMID: 37542470
Importance: Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) can affect patient health-related quality of life (HRQoL). Appropriate information may improve their adherence to treatment and quality of life. Objective: To evaluate the change...
8.
Hernando J, Kolarova T, Verslype C, Kaltsas G, Houchard A, Gueguen D, et al.
J Neuroendocrinol
. 2023 Jun;
35(6):e13281.
PMID: 37290479
Lanreotide autogel/depot (LAN) is a somatostatin analog used in first-line treatment for neuroendocrine tumors (NETs). The aim of HomeLAN was to evaluate the satisfaction with injection experience among patients with...
9.
OToole D, Kunz P, Webb S, Goldstein G, Khawaja S, McDonnell M, et al.
Adv Ther
. 2022 Dec;
40(2):671-690.
PMID: 36502449
Introduction: Real-world data evaluating patients' injection experiences using the latest devices/formulations of the long-acting (LA) somatostatin analogs (SSAs) lanreotide Autogel/Depot (LAN; Somatuline®) and octreotide LA release (OCT; Sandostatin®) are limited....
10.
Boguszewski C, Korbonits M, Artignan A, Garcia A, Houchard A, Ribeiro-Oliveira Jr A, et al.
Endocrine
. 2022 Nov;
79(3):527-536.
PMID: 36369434
Purpose: A systematic literature review was conducted to assess the use of home injections (self/partner/healthcare provider [HCP]-administered) of somatostatin analogs (SSAs) as an alternative to healthcare-setting injections in patients with...